UHS
50
4
CA
19
6
FTI
61
5
EXPD
29
2
PRU
39
3
CMI
49
2
AAPL
64
3
GWW
50
9
NEE
39
9
NRG
32
5
SIG
52
5
ORCL
49
3
SO
48
6
HSIC
42
2
PVH
58
5
KEY
24
2
GOOG
77
14
TAP
57
6
EOG
28
2
JNPR
59
3
UHS
50
4
CA
19
6
FTI
61
5
EXPD
29
2
PRU
39
3
CMI
49
2
AAPL
64
3
GWW
50
9
NEE
39
9
NRG
32
5
SIG
52
5
ORCL
49
3
SO
48
6
HSIC
42
2
PVH
58
5
KEY
24
2
GOOG
77
14
TAP
57
6
EOG
28
2
JNPR
59
3
Financhill
Back

Lucid Group 10K Form

Buy
58

LCID
Lucid Group

Last Price:
$3.01
Seasonality Move:
24.11%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive LCID News And Ratings

See the #1 stock for the next 7 days that we like better than LCID

LCID Financial Statistics

Sales & Book Value

Annual Sales: $595.3M
Cash Flow: $-622.5M
Price / Cash Flow: 0
Annual Sales: $1.15
Price / Book: 3.38

Profitability

EPS (TTM): -1.34000
Net Income (TTM): $-3B
Gross Margin: $-1.3B
Return on Equity: -71.79%
Return on Assets: -34.49%

Lucid Group Earnings Forecast

Key Lucid Group Financial Ratios

  • The Gross Profit Margin over the past 5 years for LCID is -225.24%.
  • The Selling, General & Administrative Expenses for LCID have been equal to 133.93% of Gross Profit Margin.
  • The Research & Development expenses have been 157.41% of Revenue.
  • The Interest Expense is -0.88% of Operating Income.
  • The Net Earning history of LCID is -475.15% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 3 years.

Lucid Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Automobiles
Sector: Consumer Discretionary
Current Symbol: LCID
Website: lucidmotors.com

Debt

Debt-to-Equity Ratio: 0.76
Current Ratio: 3.71
Quick Ratio: 3.12

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

LCID Technical Analysis vs Fundamental Analysis

Buy
58
Lucid Group (LCID) is a Buy

Is Lucid Group a Buy or a Sell?

  • Lucid Group stock is rated a Buy
    The current Lucid Group [LCID] share price is $3.01. The Score for LCID is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.